131 related articles for article (PubMed ID: 23009294)
1. Malignancy rates of non-masslike enhancement on breast magnetic resonance imaging using American College of Radiology Breast Imaging Reporting and Data System descriptors.
Wilhelm A; McDonough MD; DePeri ER
Breast J; 2012; 18(6):523-6. PubMed ID: 23009294
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of suspicious nipple discharge by magnetic resonance mammography based on breast imaging reporting and data system magnetic resonance imaging descriptors.
Tokuda Y; Kuriyama K; Nakamoto A; Choi S; Yutani K; Kunitomi Y; Haneda T; Kawai M; Masuda N; Takeda M; Nakamura H
J Comput Assist Tomogr; 2009; 33(1):58-62. PubMed ID: 19188786
[TBL] [Abstract][Full Text] [Related]
3. Categorization of non-mass-like breast lesions detected by MRI.
Sakamoto N; Tozaki M; Higa K; Tsunoda Y; Ogawa T; Abe S; Ozaki S; Sakamoto M; Tsuruhara T; Kawano N; Suzuki T; Yamashiro N; Fukuma E
Breast Cancer; 2008; 15(3):241-6. PubMed ID: 18224381
[TBL] [Abstract][Full Text] [Related]
4. Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement.
Tozaki M; Igarashi T; Fukuda K
AJR Am J Roentgenol; 2006 Aug; 187(2):313-21. PubMed ID: 16861532
[TBL] [Abstract][Full Text] [Related]
5. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
[TBL] [Abstract][Full Text] [Related]
6. [Non-masslike enhancement on breast MRI: interpretation pearls].
Thomassin-Naggara I; Salem C; Darai E; Bazot M; Uzan S; Marsault C; Chopier J
J Radiol; 2009 Mar; 90(3 Pt 1):269-75. PubMed ID: 19421111
[TBL] [Abstract][Full Text] [Related]
7. Non mass-like enhancement categories detected by breast MRI and histological findings.
Ballesio L; Di Pastena F; Gigli S; D'ambrosio I; Aceti A; Pontico M; Manganaro L; Porfiri LM; Tardioli S
Eur Rev Med Pharmacol Sci; 2014; 18(6):910-7. PubMed ID: 24706319
[TBL] [Abstract][Full Text] [Related]
8. Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage.
Ghanouni P; Kurian AW; Margolis D; Hartman AR; Mills MA; Plevritis SK; Ford JM; Daniel BL
Breast J; 2007; 13(3):281-6. PubMed ID: 17461903
[TBL] [Abstract][Full Text] [Related]
9. The BI-RADS breast magnetic resonance imaging lexicon.
Molleran V; Mahoney MC
Magn Reson Imaging Clin N Am; 2010 May; 18(2):171-85, vii. PubMed ID: 20494304
[TBL] [Abstract][Full Text] [Related]
10. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
[TBL] [Abstract][Full Text] [Related]
11. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.
Wang LC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):826-31. PubMed ID: 19696298
[TBL] [Abstract][Full Text] [Related]
12. Breast imaging: is the sonographic descriptor of orientation valid for magnetic resonance imaging?
Oliveira TM; Brasileiro Sant'Anna TK; Mauad FM; Elias J; Muglia VF
J Magn Reson Imaging; 2012 Dec; 36(6):1383-8. PubMed ID: 22911937
[TBL] [Abstract][Full Text] [Related]
13. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
14. Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?
Langer SA; Horst KC; Ikeda DM; Daniel BL; Kong CS; Dirbas FM
Am J Surg; 2005 Oct; 190(4):633-40. PubMed ID: 16164938
[TBL] [Abstract][Full Text] [Related]
15. High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision.
Londero V; Zuiani C; Linda A; Girometti R; Bazzocchi M; Sardanelli F
AJR Am J Roentgenol; 2012 Aug; 199(2):W240-50. PubMed ID: 22826427
[TBL] [Abstract][Full Text] [Related]
16. High-spatial-resolution 3-T breast MRI of nonmasslike enhancement lesions: an analysis of their features as significant predictors of malignancy.
Uematsu T; Kasami M
AJR Am J Roentgenol; 2012 May; 198(5):1223-30. PubMed ID: 22528918
[TBL] [Abstract][Full Text] [Related]
17. Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.
Ogura A; Hayakawa K; Yoshida S; Maeda F; Saeki F; Syukutani A
J Comput Assist Tomogr; 2011; 35(6):749-52. PubMed ID: 22082548
[TBL] [Abstract][Full Text] [Related]
18. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
19. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
20. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement.
Carbonaro LA; Verardi N; Di Leo G; Sardanelli F
Invest Radiol; 2010 Mar; 45(3):114-20. PubMed ID: 20065856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
